Description
Microbiologics has an extensive biobank comprising more than 11,000 clinical pathogens, including those with characterized resistance, to screen compounds against. Their team is highly skilled in standard and custom in vitro assays for antibacterial and antifungal R&D, as well as microbiome studies. Assays include susceptibility testing, mechanism of action, resistance development, time-kill, drug combination testing, test method development, beta-lactamase assays, phage assays, and many more. They have experience working with a wide variety of organisms including anaerobes, yeast, mold, and cell culture for intracellular activity with NTM, GC, and Chlamydia.